NEW YORK, March 20 - Aclara Biosciences has appointed Thomas Klopack CEO, the company said today.
Klopack, who was COO of Aurora Biosciences from 1998 until 2002, fills a position that has gone through a bit of musical chairs in the past few months: CEO Joseph Limber left last December, and Ed Hurwitz, a board member, was appointed interim CEO at the time, then stepped down Feb. 21. The company temporarily filled the management gap by bringing back Limber and recruiting board member Andre Marion to lead the company together as "the office of the president".
These changes come as the company shifts from a focus on microfluidics to assays that can be run on standard sequencing equipment, Jon Miller, director of corporate development, told GenomeWeb last month.
Klopack managed the operations of